PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

University of Houston researchers create new treatment and vaccine for flu and various coronaviruses

Team develops two nasal sprays – an immune activator and a new vaccine – to prevent virus transmission

University of Houston researchers create new treatment and vaccine for flu and various coronaviruses
2024-08-06
(Press-News.org) A team of researchers, led by the University of Houston, has discovered two new ways of preventing and treating respiratory viruses. In back-to-back papers in Nature Communications, the team - from the lab of Navin Varadarajan, M.D. Anderson Professor of William A. Brookshire Chemical and Biomolecular Engineering - reports the development and validation of NanoSTING, a nasal spray, as a broad-spectrum immune activator for controlling infection against multiple respiratory viruses; and the development of NanoSTING-SN, a pan-coronavirus nasal vaccine, that can protect against infection and disease by all members of the coronavirus family. 

NanoSTING Therapeutic HIGHLIGHTS 

-- NanoSTING, a nasal spray, can prevent multiple respiratory viruses by activating the immune system and preventing infection from viruses. It can also protect against SARS-CoV-2 reinfection. 

-- A single intranasal dose of the NanoSTING has proven effective against strains of SARS-CoV-2 and the flu virus.  

-- NanoSTING is complementary to vaccines and enables cells to be in a heightened state of alert to prevent attack from respiratory viruses.   

NanoSTING-NS Pan-coronavirus Vaccine HIGHLIGHTS 

-- UH researchers have developed NanoSTING-SN, a nasal vaccine that prevents transmission to the unvaccinated and fights multiple COVID variants. 

-- NanoSTING-SN provides the exciting potential towards a universal coronavirus vaccine and may end the cycle of onward transmission and viral evolution in immunocompromised people.  

-- Intramuscular vaccines prevent disease but are less efficient in preventing infections. NanoSTING-SN can provide improved protection against transmission for COVID variants and related sarbecoviruses. 

NanoSTING 

NanoSTING is a special formula that uses tiny fat droplets to deliver an immune-boosting ingredient called cGAMP. This formula helps the body's cells stay on high alert to prevent attack from respiratory viruses. 

“Using multiple models, the team demonstrated that a single treatment with NanoSTING not only protects against pathogenic strains of SARS-CoV-2 but also prevents transmission of highly transmissible variants like the Omicron variants,” reports Varadarajan. “Delivery of NanoSTING to the nose ensures that the immune system is activated in the nasal compartment and this in turn prevents infection from viruses.” 

As the recent COVID19 pandemic illustrated, the development of off-the-shelf treatments that counteract respiratory viruses is a largely unsolved problem with a huge impact on human lives.  

“Our results showed that intranasal delivery of NanoSTING, is capable of eliciting beneficial type I and type III interferon responses that are associated with immune protection and antiviral benefit,” reports first author and postdoctoral associate, Ankita Leekha. 

The authors further show that NanoSTING can protect against both Tamiflu sensitive and resistant strains of influenza, underscoring its potential as a broad-spectrum therapeutic.  

“The ability to activate the innate immune system presents an attractive route to armoring humans against multiple respiratory viruses, viral variants and also minimizing transmission to vulnerable people,” said Leekha. “The advantage of NanoSTING is that only one dose is required unlike the antivirals like Tamiflu that require 10 doses.”  

The mechanism of action of NanoSTING is complementary to vaccines, monoclonal antibodies and antivirals, the authors noted. 

Nano STING-SN 
 
Despite the successful implementation of multiple vaccines against SARS-CoV-2, these vaccines need constant updates due to viral evolution, plus the current generation of vaccines only offers limited protection against transmission of SARS-CoV-2. 

Enter NanoSTING-SN, a multi-antigen, intranasal vaccine, that eliminates virus replication in both the lungs and the nostrils and has the ability to protect against multiple coronaviruses and variants. 

“Using multiple preclinical models, the team demonstrated that the vaccine candidate protects the primary host from disease when challenged with highly pathogenic variants. Significantly, the vaccine also prevents transmission of highly transmissible variants like the Omicron variants to vaccine-naïve hosts,” reports Varadarajan.   

The authors further show that the nasal vaccine was 100% effective at preventing transmission of the Omicron VOCs to unvaccinated hosts. 

“The ability to protect against multiple coronaviruses and variants provides the exciting potential towards a universal coronavirus vaccine,” said Leekha. “The ability to prevent infections and transmission might finally end this cycle of onward transmission and viral evolution in immunocompromised people.” 

The research was conducted by a collaborative team at UH including Xinli Liu, College of Pharmacy and Vallabh E. Das, College of Optometry along with Brett L. Hurst of Utah State University and consultation from AuraVax Therapeutics, a spinoff from Varadarajan’s Single Cell Lab at UH, which is developing NanoSTING. 

Funding for the studies was provided by NIH (R01GM143243), Owens Foundation, and AuraVax Therapeutics. 

  

END

[Attachments] See images for this press release:
University of Houston researchers create new treatment and vaccine for flu and various coronaviruses

ELSE PRESS RELEASES FROM THIS DATE:

People's moral values change with the seasons

Peoples moral values change with the seasons
2024-08-06
A new UBC study has revealed regular seasonal shifts in people’s moral values. The finding has potential implications for politics, law and health—including the timing of elections and court cases, as well as public response to a health crisis. The research published this week in Proceedings of the National Academy of Sciences (PNAS) analyzed survey responses from more than 230,000 people in the U.S. over 10 years and revealed that people’s embrace of certain moral ...

Researchers reveal atomic-scale details of catalysts’ active sites

Researchers reveal atomic-scale details of catalysts’ active sites
2024-08-06
The chemical and energy industries depend upon catalysts to drive the reactions used to create their products. Many important reactions use heterogeneous catalysts — meaning that the catalysts are in a different phase of matter than the substances they are reacting with, such as solid platinum reacting with gases in an automobile’s catalytic converter. Scientists have investigated the surface of well-defined single crystals, illuminating the mechanisms underlying many chemical reactions. However, there is much more to be learned. For heterogeneous catalysts, their 3D atomic structure, their chemical composition and the nature of ...

The prescription for a healthier democracy

2024-08-06
When we’re sick, the first step on the road to recovery is a visit to the doctor’s office.  It turns out the same may also be true for breathing life into America’s democracy. A Rutgers University–New Brunswick study published in the journal JAMA Health Forum finds that physicians can play a crucial role in strengthening political inclusion of marginalized groups by aiding patients in voter registration. “Hospitals aren’t the first place we think of when it comes to voter registration,” said Katherine McCabe, an associate professor of American politics at Rutgers University-New Brunswick and lead ...

New substrate material for flexible electronics could help combat e-waste

2024-08-06
Electronic waste, or e-waste, is a rapidly growing global problem, and it’s expected to worsen with the production of new kinds of flexible electronics for robotics, wearable devices, health monitors, and other new applications, including single-use devices. A new kind of flexible substrate material developed at MIT, the University of Utah, and Meta has the potential to enable not only the recycling of materials and components at the end of a device’s useful life, but also the scalable manufacture of more ...

Johns Hopkins Medicine scientists probe molecular cause of COVID-19 related diarrhea, revealing potential treatments

2024-08-06
Working with human stem cells that form a kind of “mini intestine-in-a-dish,” Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it. Details of the experiments in a model of human intestinal tissue, called enteroids, are described on July 30 in Cellular and Molecular Gastroenterology and Hepatology. Along with the unpleasant aches, fever, sore throat, cough, respiratory distress and other symptoms that may accompany COVID-19 infection, up to half of people who get the virus will experience diarrhea. Some 30% of them will go on to develop ...

New open-source platform for high-resolution spatial transcriptomics

New open-source platform for high-resolution spatial transcriptomics
2024-08-06
Leuven, 6 August 2024 - A team of researchers from the lab of Prof. Stein Aerts (VIB-KU Leuven) presents Nova-ST, a new spatial transcriptomics technique that promises to transform gene expression profiling in tissue samples. Nova-ST will make large-scale, high-resolution spatial tissue analysis more accessible and affordable, offering significant benefits for researchers. The research was published in Cell Reports Methods. Transcriptomics is the study of gene expression in a cell or a population of cells, but it usually does not include spatial information about where those genes were active. This hurdle limited our understanding of complex ...

Targeted cancer therapy: initial high concentration may slow down selection for resistance

Targeted cancer therapy: initial high concentration may slow down selection for resistance
2024-08-06
BUFFALO, NY- August 6, 2024 – On July 28, 2024, Mikhail V. Blagosklonny M.D., Ph.D., from Roswell Park Comprehensive Cancer Center published a new editorial in Volume 16, Issue 14 of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), entitled, “Targeted cancer therapy: the initial high concentration may slow down the selection for resistance.” “Unfortunately, any targeted therapy is, always, started with low levels of the drug in the organism, selecting for drug resistance. One should propose that initial drug levels must be maximized, ...

Lehigh University researchers dig deeper into stability challenges of nuclear fusion—with mayonnaise

Lehigh University researchers dig deeper into stability challenges of nuclear fusion—with mayonnaise
2024-08-06
Mayonnaise continues to help researchers better understand the physics behind nuclear fusion. “We’re still working on the same problem, which is the structural integrity of fusion capsules used in inertial confinement fusion, and Hellmann’s Real Mayonnaise is still helping us in the search for solutions,” says Arindam Banerjee, the Paul B. Reinhold Professor of Mechanical Engineering and Mechanics at Lehigh University and Chair of the MEM department in the P.C. Rossin College of Engineering and Applied Science.  In simple terms, fusion reactions are what power the sun. If the process could ...

Texas Tech professor receives grant for printable semiconductors research

2024-08-06
Minxiang “Glenn” Zeng, an assistant professor in the Department of Chemical Engineering at Texas Tech University, has been awarded a $250,000 grant from the Launching Early-Career Academic Pathways in the Mathematical and Physical Sciences (LEAPS-MPS) award from the National Science Foundation (NSF) to further his research about printable semiconductors and electronics under extreme environments.   The grant supports Zeng’s work in understanding and controlling the thermal degradation pathways of printed metal chalcogenides, which are semiconductor materials including selenides, tellurides and sulfides. His goal is to develop strategies to enhance the thermal stability ...

Digital Olfaction Society 2024: Revolutionizing scent digitization and global transfer

Digital Olfaction Society 2024: Revolutionizing scent digitization and global transfer
2024-08-06
The 8th Annual Meeting of the Digital Olfaction Society (DOS) will take place on December 5-6, 2024, in Tokyo, Japan, and Online. The DOS meeting is uniquely aimed at digitizing scents, transferring them, and re-creating them in different parts of the world. The two-day event includes one day dedicated to talks and another day for demonstrations. Under the slogan "Olfaction to Digital Olfaction", the congress will explore the latest advances in olfaction science and digital olfaction technologies, highlighting their transformative impact across multiple fields. The first day of the congress will focus on olfaction science, scent-based diagnosis and treatment ...

LAST 30 PRESS RELEASES:

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

IPK-led research team provides insights into the pangenome of barley

New route to fluorochemicals: fluorspar activated in water under mild conditions

Microbial load can influence disease associations

Three galactic “red monsters” in the early Universe

First ever study finds sexual and gender minority physicians and residents have higher levels of burnout, lower professional fulfillment

Astronomers discover mysterious ‘Red Monster’ galaxies in the early Universe

The secrets of fossil teeth revealed by the synchrotron: a long childhood is the prelude to the evolution of a large brain

Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder

Does AI improve doctors’ diagnoses? Study puts it to the test

Extreme weather accelerates nitrate pollution in groundwater

Burden of liver cancer attributable to hepatitis B and alcohol globally, in China, and for five sociodemographic index regions from 1990 to 2021

Lehigh partners with North Carolina A&T to enhance flood damage mapping with AI and advanced radar

2024 AAAS Kavli Science Journalism Award winners named

Collaborative of prominent academic institutions launches groundbreaking healthcare AI challenge

American Federation for Aging Research announces 2024 AFAR grants for junior faculty

Potential single-dose smallpox and mpox vaccine moves forward

Mass General Brigham Gene and Cell Therapy Institute names Spark Grant recipients

New discovery may lead to more effective treatment for cardiovascular disease

Developing advanced recycling technology to restore spent battery cathode materials

An advance toward inhalable mRNA medications, vaccines

A step toward safer X-rays with new detector technology

On the origin of life: How the first cell membranes came to exist

[Press-News.org] University of Houston researchers create new treatment and vaccine for flu and various coronaviruses
Team develops two nasal sprays – an immune activator and a new vaccine – to prevent virus transmission